Use of synthetic equivalents of dipolar [C2] 2/2+ -synthons for synthesis of biologically active heterocyclic assemblies with coumarin links

S. N. Kovalenko , V. P. Chernykh , Ya. V. Belokon , I. V. Orlenko , I. A. Zhuravel , V. M. Nikitchenko , A. V. Silin

Kazan medical journal ›› 1995, Vol. 76 ›› Issue (3) : 189 -193.

PDF
Kazan medical journal ›› 1995, Vol. 76 ›› Issue (3) : 189 -193. DOI: 10.17816/kazmj100584
Pharmacy
research-article

Use of synthetic equivalents of dipolar [C2] 2/2+ -synthons for synthesis of biologically active heterocyclic assemblies with coumarin links

Author information +
History +
PDF

Abstract

Within the synthon approach the analysis of synthetical potential of the dipolar [C2] 2/2+ - synthons is performed. The possible reaction pathways of cyclization of the dipolar electrophilic [C2]22+ -synthons with the dipolar nucleophilic [SN]32-, [SN]42-, [CN]32-[N2]32--synthons are determined. As synthetical equivalents of [C2]22+-synthons, 3-(α-bromoacetyl) coumarins are chosen. On the basis of the new and improved methods of syntheseis two- and threelink biologically active assemlies of cycles with terminal coumarin links containing thriazole, indolizine, azoindolizine, 1, 3, 4-thiadiazine, furane, quinoxaline and oxazole rings are synthesized. The biological activity of 3-thiazolylcoumarins is investigated. It is stated that all of the compounds under investigation are low toxic and some of them manifest the pronounetd diuretic, antiinflammatory and membrane-stabilizing activities.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
S. N. Kovalenko, V. P. Chernykh, Ya. V. Belokon, I. V. Orlenko, I. A. Zhuravel, V. M. Nikitchenko, A. V. Silin. Use of synthetic equivalents of dipolar [C2] 2/2+ -synthons for synthesis of biologically active heterocyclic assemblies with coumarin links. Kazan medical journal, 1995, 76(3): 189-193 DOI:10.17816/kazmj100584

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Журавель И. А., Коваленко С. Н. и др.// Сборник трудов Рязанского мед. ин-та.—Рязань, 1991.—С. 75—83

[2]

Журавель И. А., Коваленко С. Н. и др.// Фармац. журнал.—1991.—№ 4.—С. 72—76

[3]

Машковский М. Д. Лекарственные средства: В 2-х томах. Т. 2—10-е изд. стер.— М., 1986

[4]

Ягодинец П. И., Скрипская О. В., Федориев Н. И., Чернюк И. Н.// Деп. Укр. НИИНТИ 22.08.90, № 1391-Ук90

[5]

Andreani A., Rambalbi M., Andreani F., Bossa R.//Ear. J. Med. Chem.— 1988.— Vol. 23.—P. 385

[6]

Andreani A., Rambalbi M., Locatelli A., Isetta A. M.//Eur. J. Med. Chem.— 1991.— Vol. 26,— P. 335

[7]

Chuev V. P., Lyaghina L. A., Kovalenko S. V.//Sibirian J. Chem.—1991.— Vol. 5.— P. 158—159

[8]

Ebeid M. Y., Amin K. M., Hussein M. M.// Egypt. J. Pharm.— Sei.— 1987.— Vol. 28.— P. 183—191

[9]

El-Morsy S. S., Fadda A. A., El-Hossi- ni M. S.//J. Ind. Chem. Soc.— 1988.— VoL 65.—P. 699—701

[10]

Kaminski J. J.//J. Med. Chem.— 1989.— Vol. 32.—P. 1686

[11]

Koelsch C. F.//J. Am. Chem. Soc.— 1950,—Vol. 72—. P. 2993—2995

[12]

Mase T., Hidek A., Kemichi T.//J. Med. Chem.— 1986,—Vol. 29.—P. 386

[13]

Rao V. R., Rao T. V. P.//Ind. J. Chem.— 1986.—Vol. 25B.— P. 413—415

[14]

Vserabhadraiah U., Rao V. R.//d, Ind. Chem. Soc.— 1990 —Vol. 67, № 1.—P. 81—82

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

47

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/